Dental Professionals
Dental Patients
Orthopedic Professionals
Orthopedic Patients
About Us
Jobs
News
International English International German
Russian Language Spanish Language
Australia and New Zealand Brasil China France Germany India Italy Japan Korea United Kingdom USA
Contact us

Geistlich Sons Limited
Thorley House,
Bailey Lane, Manchester Airport,
GB - Manchester M90 4AB

Phone: +44 161 490 2038
Fax: +44 161 498 6988
info@geistlich.co.uk

Write us
© 2025
Contact Privacy Policy Imprint Sitemap Geistlich Holding
Dental Professionals
Education
Education Hub
Courses & Congresses
Webinar World Tour
Products
Products overview
Bone Substitutes
Geistlich Bio-Oss Geistlich Bio-Oss Pen Geistlich Bio-Oss Collagen Geistlich Combi-Kit E-Shop UK E-Shop Ireland
Membranes
Geistlich Bio-Gide Geistlich Bio-Gide Compressed Geistlich Bio-Gide Perio Geistlich Bio-Gide Shape Geistlich Combi-Kit E-Shop UK E-Shop Ireland
Matrices
Mucograft Mucograft Seal Fibro-Gide E-Shop UK E-Shop Ireland
3-D Titanium Scaffold
Yxoss CBR E-Shop UK E-Shop Ireland
REGENFAST
Geistlich Select REGENFAST E-Shop UK E-Shop Ireland
Pocket-X
Pocket-X Gel E-Shop UK E-Shop Ireland
RPM
REINFORCED PTFE MESCH E-Shop UK E-Shop Ireland
Instruments
Micross SafeScraper TWIST Safescraper Twist Curve Volumizer E-Shop UK E-Shop Ireland
Fastening System
Geistlich Tack System E-Shop UK E-Shop Ireland
Therapeutic Areas
Therapeutic Areas overview
Extraction Socket Management
Immediate implant placement Early implant placement Delayed/Late implant placement No implant placement
Minor Bone Augmentation
Major Bone Augmentation
Sinus Floor Elevation
Lateral Sinus Floor Elevation Crestal Sinus Floor Elevation Sinus Floor Elevation and Bone Augmentation Prevention of Sinus Floor Augmentation
Soft-tissue Regeneration
Soft-Tissue Thickness Augmenation Gain of Keratinized Tissue Socket Seal Recession Coverage
Peri-Implantitis
Periodontal Treatment
E-Shops
Patient Information
Quality & Safety
Scientific Evidence
PIC Dental
e-IFU Dental
Downloads
FAQ
Dental Patients
Receding gums
Dental Implants
Periodontitis
Tooth Removal
What are biomaterials
Download
FAQ
Orthopedic Professionals
Bone Regeneration
General Information
Orthoss
Orthoss Collagen
Cartilage Regeneration
General Information
Chondro-Gide Jubilee Chondro-Gide
AMIC Chondro-Gide
AMIC Knee AMIC Talus AMIC Hip AMIC MTP
AMIC arthroscopic instruments
AMMR
Surgical Videos
AMIC DataBank
Partner Products
OrthoPure XT
Lipogems
Education Orthopedic
Courses and Congresses
The Geistlich Ortho Team
Product Safety
PIC Orthopedic
Downloads
Orthopedic Patients
About AMIC
Cartilage Regeneration
Bone Regeneration
Downloads
About Us
Geistlich Pharma
Our Company
Our History
What defines us
Our Commitment
News
Jobs & Career
Employer
Jobs
Home / Dental Professionals / Therapeutic Areas / Periodontal Treatment

Periodontal Treatment -
The Importance of Saving Teeth

Therapeutic Areas overview Extraction Socket Management Minor Bone Augmentation Major Bone Augmentation Sinus Floor Elevation Soft-tissue Regeneration Peri-Implantitis Periodontal Treatment
Immediate implant placement Early implant placement Delayed/Late implant placement No implant placement
Lateral Sinus Floor Elevation Crestal Sinus Floor Elevation Sinus Floor Elevation and Bone Augmentation Prevention of Sinus Floor Augmentation
Soft-Tissue Thickness Augmenation Gain of Keratinized Tissue Socket Seal Recession Coverage

Why You Should Care About Periodontal Treatment

Periodontitis is the sixth-most prevalent condition in the world.1,2 with a prevalence of 45–50%, making it the most common chronic inflammatory non-communicable human disease.2,3 

According to the Global Burden of Disease 2021 study, the prevalence of severe periodontitis was estimated at 12.5%.4 In addition, more than two-thirds of the population worldwide are reportedly affected by gingival recessions, which translates to a global prevalence of 78%.5 

Helping patients affected by gingival recessions, gingivitis, and/or periodontitis to create and maintain good oral health, function, and aesthetics is the goal of every dentist and dental hygienist. To accomplish this, various therapeutic approaches have been developed based on the grades of severity of periodontitis.

References

  1. Kassebaum NJ, et al. J Dent Res 2014; 93(11): 1045–53.
  2. Muhammad AN. Int J Health Sci (Qassim) 2017 Apr-Jun; 11(2): 72-80.
  3. Sanz M, et al. J Clin Periodontol 2020; 47 Suppl 22(Suppl 22): 4–60.
  4. Nascimento GG, et al. J Periodontal Res 2024; 59(5): 823–67.
  5. Yadav VS, et al. Oral Dis. 2023 Nov;29(8):2993-3002.
  6. Research, Science and Therapy Committee of the American Academy of Periodontology. J Periodontol. 2001 Dec;72(12):1790-800.
  7. Martínez-García M, Hernández-Lemus E. Front Physiol. 2021 Oct 27;12:709438.
  8. Matos, G.R.M., de Godoy, M.F. J. Maxillofac. Oral Surg. (2024).   
  9. Mainas G, et al. Medicina (Kaunas). 2022 May; 58(5): 621.
  10. Cortellini P, et al. J Clin Periodontol. 2020;47:768–776.
  11. Data on file. Geistlich Fibro-Gide®. Geistlich Pharma AG, Wolhusen, Switzerland.
  12. Sanz M, et al. J Clin Periodontol 2020; 47: 4-60.
  13. Millennium Research Group, Dental Biomaterials North America, 2018 (Market research).
  14. Millennium Research Group, Dental Biomaterials Europe, 2018 (Market research).
  15. Maiorana C, et al. Int J Periodontics Restorative Dent. 2005 Feb;25(1):19–25.
  16. Traini T, et al. J Periodontol. 2007 May; 78(5):955–61.
  17. Mordenfeld A, et al. Clin. Oral Implant Res. 2010, Sep;21(9):961–70.
  18. Galindo-Moreno P, et al. Clin Implant Dent Relat Res. 2013 Dec;15(6):858-66.
  19. Sculean A, et al.: J Clin Periodontol 2007; 34(1): 72-77.
  20. Ghezzi C, et al.: Int J Periodontics Restorative Dent 2012; 32(4): 433-39.
  21. Data on File. Geistlich Bio-Gide® Perio. Geistlich Pharma AG, Wolhusen, Switzerland.
  22. Instructions for Use. REGENFAST®. Mastelli.
  23. Vermeulen, V: Material Transfer Agreement Report REGENFAST 2023, Data on file, Geistlich Pharma AG.
  24. Beretta M, et al.: Int J Periodontics Restorative Dent 2024; 0(0): 1–23.
  25. Mathes SH. Et al. Biotechnol Bioeng. 2010 Dec 15;107(6):1029-39.
  26. Thoma DS, et al. Clin Oral Implants Res. 2012 Dec; 23(12): 1333–9.
  27. Thoma DS, et al. J Clin Periodontol. 2016 Oct; 43(10): 874–85.
  28. Thoma DS, et al. Clin Oral Implants Res. 2009 Sep; 20 Suppl 4: 146–65.
  29. Thoma DS, et al. J Clin Periodontol. 2014 Apr; 41 Suppl 15: S77–91.
  30. Instructions for Use. Geistlich Fibro-Gide®.  Geistlich Pharma AG, Wolhusen, Switzerland.
  31. Biocompatibility according to ISO 10993-1. Geistlich Mucograft®. Data on file, Geistlich Pharma AG, Wolhusen, Switzerland.
  32. Sanz M, et al.: J Clin Periodontol 2009; 36(10): 868-76.
  33. Konter U, et al.: Deutsche Zahnärztliche Zeitschrift 2010; 65: 723-30.
  34. Lorenzo R, et al.: Clin Oral Impl Res 2012; 23(3): 316-24.
  35. McGuire MK & Scheyer ET: J Periodontol 2010; 81(8): 1108-17.
  36. Cardaropoli D, et al.: J Periodontol 2012; 83(3): 321-28.
  37. Instructions for Use. Geistlich Mucograft®. Geistlich Pharma AG, Wolhusen, Switzerland.
  38. Information for User. Pocket-X® Gel. (Product Leaflet)
  39. Hirsch A, et al. Clin Oral Investig 2022; 26(4): 3721–33.
The progression of periodontal disease. A: Gingivitis, only affecting soft tissue. B: Periodontitis, affecting soft tissue and bone.6

Periodontitis is Associated with Systemic Diseases

Oral health is a functional, structural, aesthetic, physiological, and psychological state of wellbeing and is essential to everyone’s general health and quality of life.7–9 In recent years, several studies have reported associations between periodontitis and a number of systemic diseases, and vice versa.7–9 

References

  1. Kassebaum NJ, et al. J Dent Res 2014; 93(11): 1045–53.
  2. Muhammad AN. Int J Health Sci (Qassim) 2017 Apr-Jun; 11(2): 72-80.
  3. Sanz M, et al. J Clin Periodontol 2020; 47 Suppl 22(Suppl 22): 4–60.
  4. Nascimento GG, et al. J Periodontal Res 2024; 59(5): 823–67.
  5. Yadav VS, et al. Oral Dis. 2023 Nov;29(8):2993-3002.
  6. Research, Science and Therapy Committee of the American Academy of Periodontology. J Periodontol. 2001 Dec;72(12):1790-800.
  7. Martínez-García M, Hernández-Lemus E. Front Physiol. 2021 Oct 27;12:709438.
  8. Matos, G.R.M., de Godoy, M.F. J. Maxillofac. Oral Surg. (2024).   
  9. Mainas G, et al. Medicina (Kaunas). 2022 May; 58(5): 621.
  10. Cortellini P, et al. J Clin Periodontol. 2020;47:768–776.
  11. Data on file. Geistlich Fibro-Gide®. Geistlich Pharma AG, Wolhusen, Switzerland.
  12. Sanz M, et al. J Clin Periodontol 2020; 47: 4-60.
  13. Millennium Research Group, Dental Biomaterials North America, 2018 (Market research).
  14. Millennium Research Group, Dental Biomaterials Europe, 2018 (Market research).
  15. Maiorana C, et al. Int J Periodontics Restorative Dent. 2005 Feb;25(1):19–25.
  16. Traini T, et al. J Periodontol. 2007 May; 78(5):955–61.
  17. Mordenfeld A, et al. Clin. Oral Implant Res. 2010, Sep;21(9):961–70.
  18. Galindo-Moreno P, et al. Clin Implant Dent Relat Res. 2013 Dec;15(6):858-66.
  19. Sculean A, et al.: J Clin Periodontol 2007; 34(1): 72-77.
  20. Ghezzi C, et al.: Int J Periodontics Restorative Dent 2012; 32(4): 433-39.
  21. Data on File. Geistlich Bio-Gide® Perio. Geistlich Pharma AG, Wolhusen, Switzerland.
  22. Instructions for Use. REGENFAST®. Mastelli.
  23. Vermeulen, V: Material Transfer Agreement Report REGENFAST 2023, Data on file, Geistlich Pharma AG.
  24. Beretta M, et al.: Int J Periodontics Restorative Dent 2024; 0(0): 1–23.
  25. Mathes SH. Et al. Biotechnol Bioeng. 2010 Dec 15;107(6):1029-39.
  26. Thoma DS, et al. Clin Oral Implants Res. 2012 Dec; 23(12): 1333–9.
  27. Thoma DS, et al. J Clin Periodontol. 2016 Oct; 43(10): 874–85.
  28. Thoma DS, et al. Clin Oral Implants Res. 2009 Sep; 20 Suppl 4: 146–65.
  29. Thoma DS, et al. J Clin Periodontol. 2014 Apr; 41 Suppl 15: S77–91.
  30. Instructions for Use. Geistlich Fibro-Gide®.  Geistlich Pharma AG, Wolhusen, Switzerland.
  31. Biocompatibility according to ISO 10993-1. Geistlich Mucograft®. Data on file, Geistlich Pharma AG, Wolhusen, Switzerland.
  32. Sanz M, et al.: J Clin Periodontol 2009; 36(10): 868-76.
  33. Konter U, et al.: Deutsche Zahnärztliche Zeitschrift 2010; 65: 723-30.
  34. Lorenzo R, et al.: Clin Oral Impl Res 2012; 23(3): 316-24.
  35. McGuire MK & Scheyer ET: J Periodontol 2010; 81(8): 1108-17.
  36. Cardaropoli D, et al.: J Periodontol 2012; 83(3): 321-28.
  37. Instructions for Use. Geistlich Mucograft®. Geistlich Pharma AG, Wolhusen, Switzerland.
  38. Information for User. Pocket-X® Gel. (Product Leaflet)
  39. Hirsch A, et al. Clin Oral Investig 2022; 26(4): 3721–33.

1 Neurological diseases e.g. Alzheimer’s disease

2 Chronic respiratory diseases e.g. aspiration pneumonia

3 Cardiovascular diseases

4 Cancer e.g. colorectal cancer

5 Gastrointestinal diseases, diabetes & insulin resistance

6 Pregnancy complications

7 Rheumatoid arthritis

The Importance of Saving Teeth

Regular periodontal treatment is essential for maintaining good oral health
and preventing more serious dental problems in the future.

1. Reduction of systemic inflammation
Saving teeth by means of periodontal therapy lowers the risk of systemic inflammation, which can affect your patients’ overall health.7–9

2. Better quality of life
Patients reported a better quality of life for up to 10 years after periodontal treatment compared to those who received implants and/or bridge restorations.10 

3. Long-term tooth retention
Saving teeth for as long as possible – especially in younger patients – is one of the main goals of periodontal treatment.

4. Saves money
Periodontal therapy was shown to be a less costly alternative to tooth extraction and replacement over a period of 10 years.10 
Periodontal Treatment with Geistlich Bio-Oss® Collagen and Geistlich Bio-Gide® Perio achieves an overall tooth survival rate of 97% after 5–10 years*.11

 
*Cohort study: 1008 intrabony defects (176 patients) treated with Geistlich Bio-Oss® Collagen, with Geistlich Bio-Gide® Perio (in 50% of the cases), plus enamel matrix derivative in <10% of the cases.
 

References 

  1. Kassebaum NJ, et al.: J Dent Res 2014;93(11): 1045–53.
  2. Muhammad AN: Int J Health Sci (Qassim) 2017 Apr-Jun; 11(2): 72-80.
  3. Sanz M, et al.: J Clin Periodontol 2020; 47 Suppl 22(Suppl 22): 4–60.
  4. Nascimento GG, et al.: J Periodontal Res 2024;59(5): 823–67.
  5. Yadav VS, et al.: Oral Dis. 2023 Nov;29(8): 2993-3002.
  6. Research, Science and Therapy Committee of the American Academy of Periodontology.: J Periodontol. 2001;72(12): 1790–800.
  7. Martínez-García M, Hernández-Lemus: E. Front Physiol. 2021 Oct 27;12: 709438.
  8. Matos GRM, de Godoy MFJ: Maxillofac. Oral Surg. (2024).
  9. Mainas G, et al.: Medicina (Kaunas). 2022 May;58(5): 621.
  10. Cortellini P, et al.: J Clin Periodontol. 2020;47: 768–76.
  11. Data on file. Geistlich Fibro-Gide®. Geistlich Pharma AG, Wolhusen, Switzerland.
  12. Sanz M, et al.: J Clin Periodontol 2020;47: 4–60.
  13. Millennium Research Group, Dental Biomaterials North America, 2018 (Market research).
  14. Millennium Research Group, Dental Biomaterials Europe, 2018 (Market research).
  15. Maiorana C, et al.: Int J Periodontics Restorative Dent. 2005;25(1): 19–25.
  16. Traini T, et al.: J Periodontol. 2007;78(5): 955–61.
  17. Mordenfeld A, et al.: Clin. Oral Implant Res. 2010;21(9): 961–70.
  18. Galindo-Moreno P, et al.: Clin Implant Dent Relat Res. 2013;15(6): 858–66.
  19. Sculean A, et al.: J Clin Periodontol 2007;34(1): 72–77.
  20. Ghezzi C, et al.: Int J Periodontics Restorative Dent 2012;32(4): 433–39.
  21. Data on File. Geistlich Bio-Gide® Perio. Geistlich Pharma AG, Wolhusen, Switzerland.
  22. Instructions for Use. REGENFAST®. Mastelli.
  23. Vermeulen, V: Material Transfer Agreement Report REGENFAST 2023, Data on file, Geistlich Pharma AG.
  24. Beretta M, et al.: Int J Periodontics Restorative Dent 2025;45(2): 209–19.
  25. Mathes SH. et al.: Biotechnol Bioeng. 2010;107(6): 1029–39.
  26. Thoma DS, et al.: Clin Oral Implants Res. 2012;23(12): 1333–39.
  27. Thoma DS, et al.: J Clin Periodontol. 2016;43(10): 874–85.
  28. Thoma DS, et al.: Clin Oral Implants Res. 2009;20 Suppl 4: 146–65.
  29. Thoma DS, et al.: J Clin Periodontol. 2014;41 Suppl 15: 77–91.
  30. Instructions for Use. Geistlich Fibro-Gide®. Geistlich Pharma AG, Wolhusen, Switzerland.
  31. Biocompatibility according to ISO 10993-1. Geistlich Mucograft®. Data on file, Geistlich Pharma AG, Wolhusen, Switzerland.
  32. Sanz M, et al.: J Clin Periodontol 2009;36(10): 868–76.
  33. Konter U, et al.: Deutsche Zahnärztliche Zeitschrift 2010;65: 723–30.
  34. Lorenzo R, et al.: Clin Oral Impl Res 2012;23(3): 316–24.
  35. McGuire MK, Scheyer ET: J Periodontol 2010;81(8): 1108–17.
  36. Cardaropoli D, et al.: J Periodontol 2012;83(3): 321–28.
  37. Instructions for Use. Geistlich Mucograft®. Geistlich Pharma AG, Wolhusen, Switzerland.
  38. Information for User (Product Leaflet). Pocket-X® Gel. Prudentix.
  39. Hirsch A, et al.: Clin Oral Investig 2022;26(4): 3721–33. 

Your Solutions for Every Stage of Your Treatment

The periodontal treatment journey can be described in 4 steps according to EFP/S312 guidelines. Geistlich solutions can support you and your patients every step of the way.

Your Geistlich Biomaterials for Periodontal Treatment

Geistlich Bio-Oss®

Geistlich Bio-Oss® is the leading natural bone substitute in regenerative dentistry worldwide.13,14 With its osteo-conductive properties, Geistlich Bio-Oss® particles become an integral part of the newly formed bone and preserve volume over the long term.15–18 

More about Geistlich Bio-Oss® 

Geistlich Bio-Gide® Perio

Geistlich Bio-Gide® Perio is a collagen membrane possessing the same biological properties as Geistlich Bio-Gide® with two modified attributes: a firmer upper surface that facilitates cutting when dry, eases application in guided tissue regeneration during surgery, and retains its structural integrity even when wet.19–21 

More about Geistlich Bio-Gide® Perio

Geistlich Perio-System Combi-Pack

Perio-System Combi-Pack combines the improved handling attributes of Geistlich Bio-Oss® Collagen and Geistlich Bio-Gide® Perio. Used together, they offer optimal properties for regenerative periodontal procedures: Geistlich Bio-Oss® Collagen is easy to form and handle due to 10% porcine collagen, and Geistlich Bio-Gide® Perio offers easy handling due to its firmer upper surface that eases cutting when dry, and eases application during surgery.19–21 

More about Geistlich Bio-Oss® Collagen

More about Geistlich Bio-Gide® Perio

REGENFAST®

REGENFAST® is the first viscoelastic gel in dentistry to harness the power of polynucleotides and hyaluronic acid, stimulating tissue repair​22​ and promoting faster bone formation.​23,24​ REGENFAST® can be used in combination with autologous bone, bone substitutes​22​, membranes, and matrices.​23 

More about REGENFAST®

Geistlich Fibro-Gide®

Geistlich Fibro-Gide® is a porcine, porous, resorbable and volume-stable collagen matrix, specifically designed for soft-tissue regeneration.11,25,26 

Geistlich Fibro-Gide® is the alternative to autogenous connective tissue grafts (CTG), which are considered the gold standard in regenerative soft-tissue procedures.27–30 

More about Geistlich Fibro-Gide®

Geistlich Mucograft®

Geistlich Mucograft® is a collagen matrix designed specifically for soft-tissue regeneration in the oral cavity.31  It is indicated for gaining keratinised tissue32–34 and for recession coverage.35,36 Geistlich Mucograft® provides an alternative to autologous soft-tissue grafts.32–36 Painful harvesting of tissue is avoided, benefitting patients and clinicians alike.37 

More about Geistlich Mucograft®

Pocket-X® Gel

Pocket-X® Gel is an adjunctive subgingival treatment to improve the healing of the gingiva and to inhibit bacterial recolonisation in the periodontal pocket. Pocket-X® Gel is applied to the periodontal pocket after debridement / scaling and root planing. It can be part of a routine periodontal treatment program in cause-related therapy and supportive periodontal care (steps 2 and 4).38,39 

More about Geistlich Pocket-X® Gel

References 

  1. Kassebaum NJ, et al.: J Dent Res 2014;93(11): 1045–53.
  2. Muhammad AN: Int J Health Sci (Qassim) 2017 Apr-Jun; 11(2): 72-80.
  3. Sanz M, et al.: J Clin Periodontol 2020; 47 Suppl 22(Suppl 22): 4–60.
  4. Nascimento GG, et al.: J Periodontal Res 2024;59(5): 823–67.
  5. Yadav VS, et al.: Oral Dis. 2023 Nov;29(8): 2993-3002.
  6. Research, Science and Therapy Committee of the American Academy of Periodontology.: J Periodontol. 2001;72(12): 1790–800.
  7. Martínez-García M, Hernández-Lemus: E. Front Physiol. 2021 Oct 27;12: 709438.
  8. Matos GRM, de Godoy MFJ: Maxillofac. Oral Surg. (2024).
  9. Mainas G, et al.: Medicina (Kaunas). 2022 May;58(5): 621.
  10. Cortellini P, et al.: J Clin Periodontol. 2020;47: 768–76.
  11. Data on file. Geistlich Fibro-Gide®. Geistlich Pharma AG, Wolhusen, Switzerland.
  12. Sanz M, et al.: J Clin Periodontol 2020;47: 4–60.
  13. Millennium Research Group, Dental Biomaterials North America, 2018 (Market research).
  14. Millennium Research Group, Dental Biomaterials Europe, 2018 (Market research).
  15. Maiorana C, et al.: Int J Periodontics Restorative Dent. 2005;25(1): 19–25.
  16. Traini T, et al.: J Periodontol. 2007;78(5): 955–61.
  17. Mordenfeld A, et al.: Clin. Oral Implant Res. 2010;21(9): 961–70.
  18. Galindo-Moreno P, et al.: Clin Implant Dent Relat Res. 2013;15(6): 858–66.
  19. Sculean A, et al.: J Clin Periodontol 2007;34(1): 72–77.
  20. Ghezzi C, et al.: Int J Periodontics Restorative Dent 2012;32(4): 433–39.
  21. Data on File. Geistlich Bio-Gide® Perio. Geistlich Pharma AG, Wolhusen, Switzerland.
  22. Instructions for Use. REGENFAST®. Mastelli.
  23. Vermeulen, V: Material Transfer Agreement Report REGENFAST 2023, Data on file, Geistlich Pharma AG.
  24. Beretta M, et al.: Int J Periodontics Restorative Dent 2025;45(2): 209–19.
  25. Mathes SH. et al.: Biotechnol Bioeng. 2010;107(6): 1029–39.
  26. Thoma DS, et al.: Clin Oral Implants Res. 2012;23(12): 1333–39.
  27. Thoma DS, et al.: J Clin Periodontol. 2016;43(10): 874–85.
  28. Thoma DS, et al.: Clin Oral Implants Res. 2009;20 Suppl 4: 146–65.
  29. Thoma DS, et al.: J Clin Periodontol. 2014;41 Suppl 15: 77–91.
  30. Instructions for Use. Geistlich Fibro-Gide®. Geistlich Pharma AG, Wolhusen, Switzerland.
  31. Biocompatibility according to ISO 10993-1. Geistlich Mucograft®. Data on file, Geistlich Pharma AG, Wolhusen, Switzerland.
  32. Sanz M, et al.: J Clin Periodontol 2009;36(10): 868–76.
  33. Konter U, et al.: Deutsche Zahnärztliche Zeitschrift 2010;65: 723–30.
  34. Lorenzo R, et al.: Clin Oral Impl Res 2012;23(3): 316–24.
  35. McGuire MK, Scheyer ET: J Periodontol 2010;81(8): 1108–17.
  36. Cardaropoli D, et al.: J Periodontol 2012;83(3): 321–28.
  37. Instructions for Use. Geistlich Mucograft®. Geistlich Pharma AG, Wolhusen, Switzerland.
  38. Information for User (Product Leaflet). Pocket-X® Gel. Prudentix.
  39. Hirsch A, et al.: Clin Oral Investig 2022;26(4): 3721–33. 

Discover clinical cases and expert advice on periodontal regeneration

GERMANY
Dr. Frank Bröseler
Periodontal regenerative surgery
"Nobody wants to hide their smile"
FRANCE
Dr. Philippe Doucet
Treatment of a premolar periodontal defect in the furcation area
GERMANY
Dr. Ulrike Schulze-Spaete
Out of the palate
CANADA
Dr. Vinay Bhide
Multiple recession coverage in the maxilla
GERMANY
Prof. Dr. Peter Hahner
Pocket-X® Gel in non-surgical periodontal treatment
Downloads
Brochures and literature about Periodontal Treatment.
Arrow right
FAQ
Do you have questions?
Arrow right

Periodontal Treatment

Therapeutic Areas overview Extraction Socket Management Minor Bone Augmentation Major Bone Augmentation Sinus Floor Elevation Soft-tissue Regeneration Peri-Implantitis Periodontal Treatment
Immediate implant placement Early implant placement Delayed/Late implant placement No implant placement
Lateral Sinus Floor Elevation Crestal Sinus Floor Elevation Sinus Floor Elevation and Bone Augmentation Prevention of Sinus Floor Augmentation
Soft-Tissue Thickness Augmenation Gain of Keratinized Tissue Socket Seal Recession Coverage

Scientific background

Periodontal disease is characterised by the destruction of periodontal tissue. If non-surgical, Phase I treatment such as patient education, plaque control, scaling and root planing fails, further surgical solutions are required.

The use of biomaterials for guided tissue regeneration (GTR) is more effective than open flap debridement alone in resolving periodontal defects1. During this procedure the defect is filled with the natural bone substitute Geistlich Bio-Oss® (Collagen) and covered with the collagen membrane Geistlich Bio-Gide® (Perio).

Natural bone substitute should:

Collagen barrier membranes should:

Periodontal treatment - Decision tree
The treatment plan outlines a possible clinical methodology (adopted from Newman, Lindhe, Rateitschak2-4).

Higher attachment gain with Geistlich Bio-Oss® and Geistlich Bio-Gide® Perio

The use of a Geistlich bone substitute material together with native collagen membrane Geistlich Bio-Gide® Perio produces significantly better results than open flap debridement alone. Five-year data show higher clinical attachment level gains and greater pocket depth reduction1.

References:

  1. Sculean A et al., J Clin Periodontol. 2007 Jan;34(1):72-77 (Clinical study). 37
  2. Newman MG, et al., Caranza's Clinical Periodontology. Elsevier (Book).
  3. Lindhe J, et al., Clinical Periodontology and Implant Dentistry. Blackwell Munksgaard (Book).
  4. Rateitschak EM, Wolf HF, Farbatlanten der Zahnmedizin. Band 1: Parodontologie. Thieme (Book)
  5. Perelman-Karmon M et al. Int J Periodontics Restorative Dent. 2012 Aug;32(4):459-65. (Clinical study)
  6. Schwarz F et al. Clin. Oral Implants Res. 2006;17(4):403-409. (Pre-clinical study)
  7. Tal H et al. Clin Oral Implants Res. 2008; 19(3) : 295-302. (Clinical study)
  8. Rothamel D et al. Clin. Oral Implants Res. 2005; 16(3): 369-378. (Pre-clinical study)
  9. Zitzmann NU et al. Int J Oral Maxillofac Implants.12, 1997;844-852. (Clinical study)
  10. Rothamel D et al. Clin. Oral Implants Res. 2004;15:443-449. (Pre-clinical study)
OFD plus GTR vs. OFD alone (Sculean et al. 2007) 
Guided tissue regeneration: The reduction in pocket depth (PD) is significantly larger in the test group than in the control group with open flap debridement alone, (p≤ 0.05) both after 1 year and after 5 years.1
01/05

Clinical Cases

FLORENCE, ITALY
Dr. Pierpaolo Cortellini
Anterior maxillary periodontal regeneration in the aesthetic region
BOLOGNA, ITALY
Dr. Diego Capri
Posterior periodontal regeneration: resolving an extended three-wall defect caused by a cemental tear.
DUSSELDORF, GERMANY
Prof. Michael Christgau
Anterior mandible periodontal regeneration: resolving an extended two-wall defect.

Treatment in the aesthetic area

Case by Dr. Pierpaolo Cortellini
Florence, Italy

Clinical case

Anterior maxillary periodontal regeneration in the aesthetic region: resolving gingival recession and preventing tooth hypermobility.

 
Deep (10 mm) and wide 1-wall intrabony defect associated to tooth 11 is evident.
01/05

Geistlich Bio-Oss® and Geistlich Bio-Gide® Perio support re-establishment of full functional attachment.

Treatment in the posterior area

Case by Dr. Diego Capri
Bologna, Italy

Clinical case

Posterior periodontal regeneration: resolving an extended three-wall defect caused by a cemental tear.

 
Clinical and radiographic view of the affected area showing the lesion likely caused by a cemental tear.
01/05

Geistlich Bio-Oss® and Geistlich Bio-Gide® Perio help restore soft and hard tissue.

Treatment in the mandibular front area

Case by Prof. Michael Christgau
Dusseldorf, Germany

Clinical case

Anterior mandible periodontal regeneration: resolving an extended two-wall defect.

 
Intraoperative view of the extended 2-wall defect.
01/05

The combination of Geistlich Bio-Oss® Collagen and Geistlich Bio-Gide® Perio promotes and guides tissue regeneration.

MEMBRANES
Geistlich Bio-Gide® Perio
Geistlich Bio-Gide® Perio is a collagen membrane possessing the same biological properties as Geistlich Bio-Gide® with two modified attributes.
BONE SUBSTITUTES
Geistlich Bio-Oss® Collagen
Geistlich Bio-Oss® Collagen consists of 90% Geistlich Bio-Oss® granules and 10% porcine collagen.
MEMBRANES
Geistlich Bio-Gide®
Geistlich Bio-Gide® is a collagen membrane for reliable bone regeneration and optimal tissue integration.
BONE SUBSTITUTES
Geistlich Bio-Oss®
Geistlich Bio-Oss® is the leading natural bone substitute in regenerative dentistry worldwide.
BONE SUBSTITUTES
Perio-System Combi-Pack
Perio-System Combi-Pack combines the improved handling attributes of Geistlich Bio-Oss® Collagen 100 mg and Geistlich Bio-Gide® Perio 16 x 22 mm.